skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 293,697  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Commercialize quantum technologies in five years
Commercialize quantum technologies in five years
Material Type:
Article 		Add to My Research

Commercialize quantum technologies in five years

Nature (London), 2017-03, Vol.543 (7644), p.171-174 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/543171a ;PMID: 28277529

Full text available

Citations Cited by
2
Virtual Reality in New Product Development: Insights from Prelaunch Sales Forecasting for Durables
Virtual Reality in New Product Development: Insights from Prelaunch Sales Forecasting for Durables
Material Type:
Article 		Add to My Research

Virtual Reality in New Product Development: Insights from Prelaunch Sales Forecasting for Durables

Journal of marketing, 2022-05, Vol.86 (3), p.157-179 [Peer Reviewed Journal]

The Author(s) 2021 ;ISSN: 0022-2429 ;EISSN: 1547-7185 ;DOI: 10.1177/00222429211014902

Digital Resources/Online E-Resources

Citations Cited by
3
Accelerating innovation: some lessons from the pandemic
Accelerating innovation: some lessons from the pandemic
Material Type:
Article 		Add to My Research

Accelerating innovation: some lessons from the pandemic

Journal of Product Innovation Management, 2021-03 [Peer Reviewed Journal]

2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1111/jpim.12565

Digital Resources/Online E-Resources

Citations Cited by
4
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial
Material Type:
Article 		Add to My Research

Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Journal of hematology and oncology, 2023-02, Vol.16 (1), p.13-13, Article 13 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-023-01414-8 ;PMID: 36803531

Full text available

Citations Cited by
5
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial
Material Type:
Article 		Add to My Research

Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Journal of hematology and oncology, 2022-10, Vol.15 (1), p.159-159, Article 159 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-022-01369-2 ;PMID: 36316695

Full text available

Citations Cited by
6
Inventing Together: The Role of Actor Goals and Platform Affordances in Open Innovation
Inventing Together: The Role of Actor Goals and Platform Affordances in Open Innovation
Material Type:
Article 		Add to My Research

Inventing Together: The Role of Actor Goals and Platform Affordances in Open Innovation

Journal of the Association for Information Systems, 2022-01, Vol.23 (1), p.264 [Peer Reviewed Journal]

Copyright Association for Information Systems Jan 2022 ;ISSN: 1536-9323 ;EISSN: 1536-9323 ;DOI: 10.17705/1jais.00716

Full text available

Citations Cited by
7
0589 Listening to the Patient Voice in Sleep Apnea: Daytime Functioning and Experience with Therapy
0589 Listening to the Patient Voice in Sleep Apnea: Daytime Functioning and Experience with Therapy
Material Type:
Article 		Add to My Research

0589 Listening to the Patient Voice in Sleep Apnea: Daytime Functioning and Experience with Therapy

Sleep (New York, N.Y.), 2019-04, Vol.42 (Supplement_1), p.A234-A235 [Peer Reviewed Journal]

Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com. ;ISSN: 0161-8105 ;EISSN: 1550-9109 ;DOI: 10.1093/sleep/zsz067.587

Full text available

Citations Cited by
8
Target product profiles: leprosy diagnostics/ Profil de produit cible: diagnostic de la lepre/ Perfiles de productos objetivo: diagnostico de la lepra
Target product profiles: leprosy diagnostics/ Profil de produit cible: diagnostic de la lepre/ Perfiles de productos objetivo: diagnostico de la lepra
Material Type:
Article 		Add to My Research

Target product profiles: leprosy diagnostics/ Profil de produit cible: diagnostic de la lepre/ Perfiles de productos objetivo: diagnostico de la lepra

Bulletin of the World Health Organization, 2024-04, Vol.102 (4), p.288 [Peer Reviewed Journal]

COPYRIGHT 2024 World Health Organization ;ISSN: 0042-9686 ;EISSN: 1564-0604 ;DOI: 10.2471/BLT.23.290881

Full text available

Citations Cited by
9
The connection between ADT and evolutionary methods in product development
The connection between ADT and evolutionary methods in product development
Material Type:
Article 		Add to My Research

The connection between ADT and evolutionary methods in product development

Journal of physics. Conference series, 2021-05, Vol.1935 (1), p.12001 [Peer Reviewed Journal]

Published under licence by IOP Publishing Ltd ;2021. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1742-6588 ;EISSN: 1742-6596 ;DOI: 10.1088/1742-6596/1935/1/012001

Full text available

Citations Cited by
10
Retracted: Research on Application of 3D Simulation Technology in Industrial Product Design Technology
Retracted: Research on Application of 3D Simulation Technology in Industrial Product Design Technology
Material Type:
Article 		Add to My Research

Retracted: Research on Application of 3D Simulation Technology in Industrial Product Design Technology

Advances in multimedia, 2023-08, Vol.2023, p.1-1 [Peer Reviewed Journal]

Copyright © 2023 Advances in Multimedia. ;Copyright © 2023 Advances in Multimedia. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;ISSN: 1687-5680 ;EISSN: 1687-5699 ;DOI: 10.1155/2023/9794286

Full text available

Citations Cited by
11
014 The diagnostic odyssey for fabry disease: ten years experience in testing
014 The diagnostic odyssey for fabry disease: ten years experience in testing
Material Type:
Article 		Add to My Research

014 The diagnostic odyssey for fabry disease: ten years experience in testing

Journal of neurology, neurosurgery and psychiatry, 2018-06, Vol.89 (6), p.A7-A7 [Peer Reviewed Journal]

2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2018 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0022-3050 ;EISSN: 1468-330X ;DOI: 10.1136/jnnp-2018-ANZAN.14

Full text available

Citations Cited by
12
Adopting Design Thinking in Novice Multidisciplinary Teams: The Application and Limits of Design Methods and Reflexive Practices
Adopting Design Thinking in Novice Multidisciplinary Teams: The Application and Limits of Design Methods and Reflexive Practices
Material Type:
Article 		Add to My Research

Adopting Design Thinking in Novice Multidisciplinary Teams: The Application and Limits of Design Methods and Reflexive Practices

The Journal of product innovation management, 2013-12, Vol.30 (S1), p.19-33 [Peer Reviewed Journal]

2013 Product Development & Management Association ;Copyright Blackwell Publishing Ltd. Dec 2013 ;ISSN: 0737-6782 ;EISSN: 1540-5885 ;DOI: 10.1111/jpim.12061 ;CODEN: JPIMDD

Full text available

Citations Cited by
13
Understanding the Elusive Black Box of Dynamic Capabilities
Understanding the Elusive Black Box of Dynamic Capabilities
Material Type:
Article 		Add to My Research

Understanding the Elusive Black Box of Dynamic Capabilities

Decision sciences, 2011-02, Vol.42 (1), p.239-273 [Peer Reviewed Journal]

2011 The Authors Decision Sciences Journal © 2011 Decision Sciences Institute ;Copyright American Institute for Decision Sciences Feb 2011 ;ISSN: 0011-7315 ;EISSN: 1540-5915 ;DOI: 10.1111/j.1540-5915.2010.00287.x ;CODEN: DESCDQ

Full text available

Citations Cited by
14
Evolution of the COVID-19 vaccine development landscape
Evolution of the COVID-19 vaccine development landscape
Material Type:
Article 		Add to My Research

Evolution of the COVID-19 vaccine development landscape

Nature reviews. Drug discovery, 2020-10, Vol.19 (10), p.667-668 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Nature 2020. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-020-00151-8

Full text available

Citations Cited by
15
A Review on Extracts, Chemical Composition and Product Development of Walnut IDiaphragma Juglandis/I Fructus
A Review on Extracts, Chemical Composition and Product Development of Walnut IDiaphragma Juglandis/I Fructus
Material Type:
Article 		Add to My Research

A Review on Extracts, Chemical Composition and Product Development of Walnut IDiaphragma Juglandis/I Fructus

Foods, 2023-09, Vol.12 (18) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2304-8158 ;EISSN: 2304-8158 ;DOI: 10.3390/foods12183379

Full text available

Citations Cited by
16
Targeted protein degraders crowd into the clinic
Targeted protein degraders crowd into the clinic
Material Type:
Article 		Add to My Research

Targeted protein degraders crowd into the clinic

Nature reviews. Drug discovery, 2021-04, Vol.20 (4), p.247-250 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Nature 2021. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-021-00052-4 ;PMID: 33737725

Full text available

Citations Cited by
17
How to improve new product performance through customer relationship management and product development management: evidence from China
How to improve new product performance through customer relationship management and product development management: evidence from China
Material Type:
Article 		Add to My Research

How to improve new product performance through customer relationship management and product development management: evidence from China

The Journal of business & industrial marketing, 2021-01, Vol.36 (1), p.31-47 [Peer Reviewed Journal]

Emerald Publishing Limited ;Emerald Publishing Limited 2020 ;ISSN: 0885-8624 ;EISSN: 2052-1189 ;DOI: 10.1108/JBIM-05-2019-0190

Full text available

Citations Cited by
18
Building trust in multi-stakeholder collaborations for new product development in the digital transformation era
Building trust in multi-stakeholder collaborations for new product development in the digital transformation era
Material Type:
Article 		Add to My Research

Building trust in multi-stakeholder collaborations for new product development in the digital transformation era

Benchmarking : an international journal, 2021-01, Vol.28 (1), p.205-228 [Peer Reviewed Journal]

Emerald Publishing Limited ;Emerald Publishing Limited 2020 ;ISSN: 1463-5771 ;EISSN: 1758-4094 ;DOI: 10.1108/BIJ-04-2020-0164

Full text available

Citations Cited by
19
Trends in clinical success rates and therapeutic focus
Trends in clinical success rates and therapeutic focus
Material Type:
Article 		Add to My Research

Trends in clinical success rates and therapeutic focus

Nature reviews. Drug discovery, 2019-07, Vol.18 (7), p.495-496 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Nature 2019. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-019-00074-z ;PMID: 31267067

Full text available

Citations Cited by
20
EXPLORING SUSTAINABLE PRODUCT DEVELOPMENT PROCESSES FOR A CIRCULAR ECONOMY THROUGH MORPHOLOGICAL ANALYSIS
EXPLORING SUSTAINABLE PRODUCT DEVELOPMENT PROCESSES FOR A CIRCULAR ECONOMY THROUGH MORPHOLOGICAL ANALYSIS
Material Type:
Conference Proceeding 		Add to My Research

EXPLORING SUSTAINABLE PRODUCT DEVELOPMENT PROCESSES FOR A CIRCULAR ECONOMY THROUGH MORPHOLOGICAL ANALYSIS

Proceedings of the Design Society, 2021, Vol.1, p.1491-1500

The Author(s), 2021. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution – Non-Commercial – No Derivatives License This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2732-527X ;DOI: 10.1017/pds.2021.410

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 293,697  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (50,361)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1961  (332)
  2. 1961 To 1975  (605)
  3. 1976 To 1990  (5,413)
  4. 1991 To 2006  (151,289)
  5. After 2006  (136,044)
  6. More options open sub menu

Subject 

  1. Product Development  (290,819)
  2. Science & Technology  (29,752)
  3. Software  (28,285)
  4. Marketing  (26,859)
  5. Technology  (21,434)
  6. Innovations  (20,616)
  7. Software Industry  (17,684)
  8. Manufacturing  (16,941)
  9. Computer Software Industry  (16,531)
  10. R&d  (15,469)
  11. Research & Development  (15,207)
  12. Design  (15,195)
  13. Engineering  (15,009)
  14. Pharmaceutical Industry  (14,584)
  15. Management  (14,079)
  16. Studies  (13,647)
  17. Product Introduction  (13,414)
  18. Consumers  (12,649)
  19. Social Sciences  (12,160)
  20. Life Sciences & Biomedicine  (11,343)
  21. More options open sub menu

Language 

  1. English  (292,760)
  2. Japanese  (2,684)
  3. Portuguese  (618)
  4. German  (332)
  5. Spanish  (250)
  6. French  (187)
  7. Chinese  (86)
  8. Turkish  (45)
  9. Persian  (42)
  10. Czech  (28)
  11. Finnish  (28)
  12. Polish  (26)
  13. Norwegian  (25)
  14. Swedish  (25)
  15. Russian  (22)
  16. Croatian  (22)
  17. Indonesian  (20)
  18. Lithuanian  (18)
  19. Catalan  (16)
  20. Italian  (16)
  21. More options open sub menu

Journal Title 

  1. Automotive News  (6,181)
  2. Computerworld  (8,130)
  3. Crn  (3,078)
  4. Electronic Engineering Times  (2,188)
  5. Eweek  (3,859)
  6. Flight International  (6,559)
  7. Informationweek  (4,424)
  8. Infoworld  (5,814)
  9. Network World  (7,173)
  10. New York Times  (3,574)
  11. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait